Coverart for item
The Resource Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa : workshop summary, Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Board on Global Health ; Diana E. Pankevich, Sheena M. Posey Norris, Theresa M. Wizemann, and Bruce M. Altevogt, rapporteurs, (electronic resource)

Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa : workshop summary, Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Board on Global Health ; Diana E. Pankevich, Sheena M. Posey Norris, Theresa M. Wizemann, and Bruce M. Altevogt, rapporteurs, (electronic resource)

Label
Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa : workshop summary
Title
Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa
Title remainder
workshop summary
Statement of responsibility
Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Board on Global Health ; Diana E. Pankevich, Sheena M. Posey Norris, Theresa M. Wizemann, and Bruce M. Altevogt, rapporteurs
Creator
Contributor
Subject
Language
eng
Summary
  • "In 2011 the Grand Challenges in Global Mental Health initiative identified priorities that have the potential to make a significant impact on the lives of people with mental, neurological, and substance use disorders. Reduction of the cost and improvement of the supply of effective medicines was highlighted as one of the top five challenges. For low- and middle-income countries, improving access to appropriate essential medicines can be a tremendous challenge and a critical barrier to scaling up quality care for mental, neurological, and substance use disorders. Reduction of cost and improvement of the supply of effective medicines has the potential to significantly impact the lives of patients with these disorders. Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa is the summary of a workshop convened by the Institute of Medicine Neuroscience Forum in January 2014 in Addis Ababa, Ethiopia to discuss opportunities for achieving long-term affordable access to medicines for these disorders. This report examines challenges and opportunities for improving access to essential medicines in four critical areas: demand, selection, supply chains, and financing and pricing. The report also discusses successful activities that increase access to essential medicines both within Sub-Saharan Africa and in other developing countries, and considers the role of governments, nongovernmental organizations, and private groups in procurement of essential medicines for mental, neurological, and substance use disorders."--Publisher's description
  • "In 2011 the Grand Challenges in Global Mental Health initiative identified priorities that have the potential to make a significant impact on the lives of people with mental, neurological, and substance use disorders. Reduction of the cost and improvement of the supply of effective medicines was highlighted as one of the top five challenges. For low- and middle-income countries, improving access to appropriate essential medicines can be a tremendous challenge and a critical barrier to scaling up quality care for mental, neurological, and substance use disorders. Reduction of cost and improvement of the supply of effective medicines has the potential to significantly impact the lives of patients with these disorders. Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa is the summary of a workshop convened by the Institute of Medicine Neuroscience Forum in January 2014 in Addis Ababa, Ethiopia to discuss opportunities for achieving long-term affordable access to medicines for these disorders. This report examines challenges and opportunities for improving access to essential medicines in four critical areas: demand, selection, supply chains, and financing and pricing. The report also discusses successful activities that increase access to essential medicines both within Sub-Saharan Africa and in other developing countries, and considers the role of governments, nongovernmental organizations, and private groups in procurement of essential medicines for mental, neurological, and substance use disorders."--Publisher's description
  • "In 2011 the Grand Challenges in Global Mental Health initiative identified priorities that have the potential to make a significant impact on the lives of people with mental, neurological, and substance use disorders. Reduction of the cost and improvement of the supply of effective medicines was highlighted as one of the top five challenges. For low- and middle-income countries, improving access to appropriate essential medicines can be a tremendous challenge and a critical barrier to scaling up quality care for mental, neurological, and substance use disorders. Reduction of cost and improvement of the supply of effective medicines has the potential to significantly impact the lives of patients with these disorders. Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa is the summary of a workshop convened by the Institute of Medicine Neuroscience Forum in January 2014 in Addis Ababa, Ethiopia to discuss opportunities for achieving long-term affordable access to medicines for these disorders. This report examines challenges and opportunities for improving access to essential medicines in four critical areas: demand, selection, supply chains, and financing and pricing. The report also discusses successful activities that increase access to essential medicines both within Sub-Saharan Africa and in other developing countries, and considers the role of governments, nongovernmental organizations, and private groups in procurement of essential medicines for mental, neurological, and substance use disorders."--Publisher's description
  • "In 2011 the Grand Challenges in Global Mental Health initiative identified priorities that have the potential to make a significant impact on the lives of people with mental, neurological, and substance use disorders. Reduction of the cost and improvement of the supply of effective medicines was highlighted as one of the top five challenges. For low- and middle-income countries, improving access to appropriate essential medicines can be a tremendous challenge and a critical barrier to scaling up quality care for mental, neurological, and substance use disorders. Reduction of cost and improvement of the supply of effective medicines has the potential to significantly impact the lives of patients with these disorders. Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa is the summary of a workshop convened by the Institute of Medicine Neuroscience Forum in January 2014 in Addis Ababa, Ethiopia to discuss opportunities for achieving long-term affordable access to medicines for these disorders. This report examines challenges and opportunities for improving access to essential medicines in four critical areas: demand, selection, supply chains, and financing and pricing. The report also discusses successful activities that increase access to essential medicines both within Sub-Saharan Africa and in other developing countries, and considers the role of governments, nongovernmental organizations, and private groups in procurement of essential medicines for mental, neurological, and substance use disorders."--Publisher's description
  • "In 2011 the Grand Challenges in Global Mental Health initiative identified priorities that have the potential to make a significant impact on the lives of people with mental, neurological, and substance use disorders. Reduction of the cost and improvement of the supply of effective medicines was highlighted as one of the top five challenges. For low- and middle-income countries, improving access to appropriate essential medicines can be a tremendous challenge and a critical barrier to scaling up quality care for mental, neurological, and substance use disorders. Reduction of cost and improvement of the supply of effective medicines has the potential to significantly impact the lives of patients with these disorders. Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa is the summary of a workshop convened by the Institute of Medicine Neuroscience Forum in January 2014 in Addis Ababa, Ethiopia to discuss opportunities for achieving long-term affordable access to medicines for these disorders. This report examines challenges and opportunities for improving access to essential medicines in four critical areas: demand, selection, supply chains, and financing and pricing. The report also discusses successful activities that increase access to essential medicines both within Sub-Saharan Africa and in other developing countries, and considers the role of governments, nongovernmental organizations, and private groups in procurement of essential medicines for mental, neurological, and substance use disorders."--Publisher's description
  • "In 2011 the Grand Challenges in Global Mental Health initiative identified priorities that have the potential to make a significant impact on the lives of people with mental, neurological, and substance use disorders. Reduction of the cost and improvement of the supply of effective medicines was highlighted as one of the top five challenges. For low- and middle-income countries, improving access to appropriate essential medicines can be a tremendous challenge and a critical barrier to scaling up quality care for mental, neurological, and substance use disorders. Reduction of cost and improvement of the supply of effective medicines has the potential to significantly impact the lives of patients with these disorders. Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa is the summary of a workshop convened by the Institute of Medicine Neuroscience Forum in January 2014 in Addis Ababa, Ethiopia to discuss opportunities for achieving long-term affordable access to medicines for these disorders. This report examines challenges and opportunities for improving access to essential medicines in four critical areas: demand, selection, supply chains, and financing and pricing. The report also discusses successful activities that increase access to essential medicines both within Sub-Saharan Africa and in other developing countries, and considers the role of governments, nongovernmental organizations, and private groups in procurement of essential medicines for mental, neurological, and substance use disorders."--
Assigning source
Publisher's description
Cataloging source
BTCTA
http://library.link/vocab/creatorDate
1975-
http://library.link/vocab/creatorName
Pankevich, Diana E.
Dewey number
616.89180967
NLM call number
  • 2014 M-644
  • WM 402
http://library.link/vocab/relatedWorkOrContributorDate
2014
http://library.link/vocab/relatedWorkOrContributorName
  • Norris, Sheena M. Posey
  • Wizemann, Theresa M
  • Altevogt, Bruce M
  • Institute of Medicine (U.S.)
  • Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa (Workshop)
http://library.link/vocab/subjectName
  • Mental Disorders
  • Health Services Accessibility
  • Medically Underserved Area
  • Nervous System Diseases
  • Pharmaceutical Preparations
  • Substance-Related Disorders
  • Africa South of the Sahara
Label
Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa : workshop summary, Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Board on Global Health ; Diana E. Pankevich, Sheena M. Posey Norris, Theresa M. Wizemann, and Bruce M. Altevogt, rapporteurs, (electronic resource)
Instantiates
Publication
Bibliography note
Includes bibliographical references (pages 109-114)
Contents
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
Control code
OCM1bookssj0001424118
Dimensions
unknown
Isbn
9780309288101
Specific material designation
remote
System control number
(WaSeSS)bookssj0001424118
Label
Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa : workshop summary, Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy, Board on Global Health ; Diana E. Pankevich, Sheena M. Posey Norris, Theresa M. Wizemann, and Bruce M. Altevogt, rapporteurs, (electronic resource)
Publication
Bibliography note
Includes bibliographical references (pages 109-114)
Contents
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
  • Overview -- Challenge: Insufficient Demand -- Challenge: Inappropriate Selection -- Challenge: Ineffective Supply Chains -- Challenge: High Pricing and Poor Financing -- Perspectives on Next Steps -- Appendix A: Access to Essential Medicines: Program Examples -- Appendix B: References -- Appendix C: Workshop Agenda -- Appendix D: Registered Attendees
Control code
OCM1bookssj0001424118
Dimensions
unknown
Isbn
9780309288101
Specific material designation
remote
System control number
(WaSeSS)bookssj0001424118

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...